MDM2 |
Activation |
Erythroid |
Cell cycle, apoptosis, genomic instability, cancer |
88 |
BCL-2 |
Activation |
Erythroid |
Apoptosis, cancer |
87 |
GATA-1 |
Suppression |
Erythroid |
Cell cycle, cancer |
86 |
RB |
Suppression |
Erythroid |
Cell cycle, apoptosis, cancer |
20 |
SHIP-1 |
Suppression |
Erythroid |
Phosphatase, signal transduction, cancer |
92 |
Several ribosomal genes |
Activation |
Erythroid |
Ribosomal biogenesis, erythroid transformation |
93 |
NOTCH1 |
Activation |
T-cells |
Signal transduction, cancer |
27 |
Fli-1 |
Activation |
T-cells |
Transcriptional regulation, hematopoiesis, cancer, vasculogenesis |
25 |
SCL/TAL1 |
Activation |
Hematopoietic cells |
Hematopoiesis |
49,50
|
c-mpl, gpIIb, gpIV, gpIX, PF4, NF-E2/p45, MafG, HOxa10 and Rab27B |
Activation |
Megakaryocytes |
Megakaryopoiesis |
29,36
|
MCP-1 |
Activation |
Endothelial cells |
Chemo-attractant factor |
62 |
Tek/Tie-2 |
Activation |
Endothelial cells |
Angiogenesis, vasculogenesis |
26 |
VE-cadherin |
Activation |
Endothelial cells |
Cell junction protein interaction, angiogenesis |
44 |
VE-Statin/egf17 |
Activation |
Endothelial cells |
Controls the recruitment and proliferation of smooth muscle cells and pericytes |
56 |
VEGF-A |
Activation |
Endothelial cells |
Angiogenesis, vasculogenesis |
109 |
COL1A2 |
Suppression |
Fibroblasts |
Involved in construction of type I collagen |
72,73
|